Atlas Trials

A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02851849 · COMPLETED

Trial details

NCT number
NCT02851849
Sponsor
Ligand Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-09-01
Primary completion
2017-06-01
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.